Since chemoresistance is identified as a major obstacle for GC treatment, we investigated the effect of FOXD1‐AS1 on the resistance of GC cells to cisplatin (DDP), a commonly used chemotherapeutic drug. This evidence concerns the gene FOXD1 and gastric cancer.